ZNF37BP

Across TCGA pan-cancer cohorts, ZNF37BP Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated ZNF37BP data layer compared with 25 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ZNF37BP Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated ZNF37BP expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, HNSC, and SKCM are the cancer types where ZNF37BP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.936	0.601	.011	26	view →
HNSC	OS	Median	All	0.346	0.663	.008	18	view →
SKCM	OS	Median	III,IV	0.239	0.708	.003	13	view →
LUSC	OS	Median	II,III,IV	0.002	0.733	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

ZNF37BP–UCEC (DFS)

Open the UCEC breakdown →